Changes at Italy's drug agency AIFA and their implications for the regulator and industry
This article was originally published in SRA
Executive Summary
Laura Orlando examines what the changes means for the agency and for the pharmaceutical industry.
You may also be interested in...
Introducing The Citeline Awards 2020; Nominations Open
Sanofi CEO Hudson Delivers An Ambitious Turnaround Agenda
Sanofi Has The Fire Power For Deals, CEO Hudson Says
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: